<p>Average scores for A) the simple model or B) the comprehensive model according to fatty liver grade determined by hepatic ultrasound. All P values of comparison between any groups are <0.001. *P for trend are <0.001. Average scores for C) the simple model or D) the comprehensive model according to the fatty liver conditions defined by NAFLD fibrosis score. Subjects with negative results by NAFLD fibrosis score (N = 12046) could be excluded from having advanced fibrosis and subjects with positive results of NAFLD fibrosis score (N = 131) are highly likely to have advanced fibrosis. All P values of comparison between any groups are <0.001. *P for trend are <0.001. Data are shown as mean with SD.</p
ObjectiveTo establish a model for evaluating the severity of nonalcoholic fatty liver disease (NAFLD...
Median (IQR) NAFLD fibrosis score by FGF19 (A), C4 (B), presence of chronic diarrhea (C) or bile aci...
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of a metabolic syndrome. To d...
none17Patients with nonalcoholic fatty liver disease (NAFLD) and advanced liver fibrosis are at the ...
Patients with nonalcoholic fatty liver disease (NAFLD) and advanced liver fibrosis are at the highes...
<p>Characteristics of participants with fatty liver according to risk of fibrosis as predicted by th...
Background and Aim: Significant hepatic fibrosis is prognostic of liver morbidity and mortality in n...
<p>All p values are <0.001. CB, Clinical and biochemical; AUC, area under curve; LR, likelihood rati...
Background The presence of advanced liver fibrosis portends a poor prognosis in nonalcoholic fatty l...
Aims :To compare the NAFLD fibrosis score and FIBROSIS 4 score to fibroscan, and affirm whether the ...
Fibrosis affects prognoses for patients with nonalcoholic fatty liver disease (NAFLD). Several non-i...
To develop, validate and compare a non-invasive fibrosis scoring system for non-alcoholic fatty live...
Background In nonalcoholic fatty liver disease (NAFLD), advanced fibrosis has been identified as ...
BACKGROUND & AIMS: Fibrosis affects prognoses for patients with nonalcoholic fatty liver disease...
AIMS: To develop, validate and compare a non-invasive fibrosis scoring system for non-alcoholic fatt...
ObjectiveTo establish a model for evaluating the severity of nonalcoholic fatty liver disease (NAFLD...
Median (IQR) NAFLD fibrosis score by FGF19 (A), C4 (B), presence of chronic diarrhea (C) or bile aci...
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of a metabolic syndrome. To d...
none17Patients with nonalcoholic fatty liver disease (NAFLD) and advanced liver fibrosis are at the ...
Patients with nonalcoholic fatty liver disease (NAFLD) and advanced liver fibrosis are at the highes...
<p>Characteristics of participants with fatty liver according to risk of fibrosis as predicted by th...
Background and Aim: Significant hepatic fibrosis is prognostic of liver morbidity and mortality in n...
<p>All p values are <0.001. CB, Clinical and biochemical; AUC, area under curve; LR, likelihood rati...
Background The presence of advanced liver fibrosis portends a poor prognosis in nonalcoholic fatty l...
Aims :To compare the NAFLD fibrosis score and FIBROSIS 4 score to fibroscan, and affirm whether the ...
Fibrosis affects prognoses for patients with nonalcoholic fatty liver disease (NAFLD). Several non-i...
To develop, validate and compare a non-invasive fibrosis scoring system for non-alcoholic fatty live...
Background In nonalcoholic fatty liver disease (NAFLD), advanced fibrosis has been identified as ...
BACKGROUND & AIMS: Fibrosis affects prognoses for patients with nonalcoholic fatty liver disease...
AIMS: To develop, validate and compare a non-invasive fibrosis scoring system for non-alcoholic fatt...
ObjectiveTo establish a model for evaluating the severity of nonalcoholic fatty liver disease (NAFLD...
Median (IQR) NAFLD fibrosis score by FGF19 (A), C4 (B), presence of chronic diarrhea (C) or bile aci...
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of a metabolic syndrome. To d...